9 November 2026
Meet the opnMe team at our booth (Hall 8, 8-88) at BIO-Europe 2026 in Cologne, Germany, from 9–11 November 2026. Connect with us and discover how Boehringer Ingelheim’s open innovation platform provides scientists worldwide with opportunities to access high-quality research molecules, contribute their expertise, and collaborate with us to advance scientific discovery.
Are you interested in exploring partnership opportunities for precisely formulated discovery research questions to collaborate with scientists at Boehringer Ingelheim?
Through opnMe, we currently feature three collaboration calls:
- Humanoids for human-centric wet-lab R&D tasks
- Biomarkers linking kidney biology to cardiovascular risk in CM-CKD
- Peripheral mechanisms for negative energy balance in the context of obesity
All incoming collaboration proposals will be evaluated by our scientific jury, and, upon selection, chosen proposals are pursued through a customized partnership with the successful applicants based on appropriate business options along well-defined parameters. Proposals from seed stage biotechs may also become eligible for equity via the Boehringer Ingelheim Venture Fund.
Subscribe to our newsletter to stay updated as we add new molecules to opnMe.com.
Let’s connect at BIO-Europe
BIO-Europe is a leading global partnering event for the biotechnology and biopharma industry, bringing together biotech and pharmaceutical companies, investors, and other organizations from across the life sciences ecosystem. The 2026 edition will take place at Koelnmesse in Cologne, Germany, from 9–11 November. If you are attending, visit the opnMe booth (Hall 8, 8-88) to meet our team, discuss your science, exchange ideas, and explore how open innovation can help advance your research.
Learn more about BIO-Europe 2026.
About opnMe:
opnMe.com, the open science portal of Boehringer Ingelheim, fosters science and collaboration initiatives in areas of high unmet medical need. Our molecules are provided to the scientific community either free of charge as “Molecules to Order” or applied for via scientific research submissions as “Molecules for Collaboration”. With our current “opn2EXPERTS” calls, we enlist scientific advice on key scientific topics to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs. Our "opn2TALENTS" postdoc grants at one of our research sites offer opportunities for high-level talents to propose innovative approaches for precisely defined scientific questions.